sponsored
PatientsVille.com Logo

PatientsVille

Loratadine and Propranolol

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectLoratadinePropranolol
DRUG INEFFECTIVE4.1% 2.7%
NAUSEA3.1% 3.1%
FATIGUE3.1% 2.7%
DYSPNOEA2.9% 2.1%
HEADACHE2.6% 2.7%
DIZZINESS2.6% 2.4%
DIARRHOEA2.4% 2.2%
PAIN2.2% 1.7%
TOXICITY TO VARIOUS AGENTS0.5% 2%
COMPLETED SUICIDE0% 2%
VOMITING1.7% 1.9%
ANXIETY1.4% 1.9%
OFF LABEL USE1.9% 1.4%
MALAISE1.8% 1.6%
ASTHENIA1.6% 1.7%
DEPRESSION1.4% 1.7%
HYPOTENSION0.7% 1.7%
INSOMNIA1.5% 1.6%
FALL1.5% 1.6%
DRUG INTERACTION0.7% 1.6%
PNEUMONIA1.5% 0.9%
TREMOR0.8% 1.5%
RASH1.5% 0.8%
SOMNOLENCE1.4% 1.3%
PAIN IN EXTREMITY1.4% 1.1%
ARTHRALGIA1.4% 1.1%
COUGH1.4% 0.9%
PYREXIA1.3% 1.1%
CONFUSIONAL STATE0.9% 1.3%
PRURITUS1.3% 0.8%
WEIGHT DECREASED1.1% 1.2%
BACK PAIN1.2% 0.9%
CHEST PAIN1.2% 0.9%
OVERDOSE0.5% 1.2%
BRADYCARDIA0% 1.2%
CARDIAC ARREST0% 1.2%
CONDITION AGGRAVATED1.1% 1.1%
FEELING ABNORMAL1.1% 1.1%
HYPERTENSION1% 1.1%
WEIGHT INCREASED1% 1.1%
ABDOMINAL PAIN0.9% 1.1%
DEATH0.9% 1%
HYPERHIDROSIS0.7% 1%
CONSTIPATION1% 0.7%
SUICIDAL IDEATION0.5% 1%
URTICARIA1% 0%
DECREASED APPETITE0.9% 0.9%
PALPITATIONS0.7% 0.9%
ANAEMIA0.7% 0.9%
PARAESTHESIA0.7% 0.9%
GAIT DISTURBANCE0.7% 0.9%
ABDOMINAL PAIN UPPER0.9% 0.7%
MUSCLE SPASMS0.9% 0.6%
HYPERSENSITIVITY0.9% 0.5%
ASTHMA0.9% 0%
MIGRAINE0% 0.9%
DRUG DOSE OMISSION0.8% 0.7%
BLOOD PRESSURE INCREASED0.7% 0.8%
MEMORY IMPAIRMENT0.6% 0.8%
HYPOAESTHESIA0.8% 0.6%
URINARY TRACT INFECTION0.8% 0.6%
LOSS OF CONSCIOUSNESS0.6% 0.8%
VISION BLURRED0.6% 0.8%
SINUSITIS0.8% 0%
MYALGIA0.7% 0.7%
OEDEMA PERIPHERAL0.7% 0.6%
DEHYDRATION0.7% 0.6%
RENAL FAILURE0.7% 0.6%
ALOPECIA0.7% 0.6%
AGITATION0.5% 0.7%
CHEST DISCOMFORT0.7% 0.5%
ACUTE KIDNEY INJURY0.7% 0.5%
CARDIO-RESPIRATORY ARREST0% 0.7%
GASTROOESOPHAGEAL REFLUX DISEASE0.7% 0%
NASOPHARYNGITIS0.7% 0%
CHRONIC KIDNEY DISEASE0.7% 0%
SYNCOPE0.6% 0.6%
HEART RATE INCREASED0.6% 0.6%
ABDOMINAL DISCOMFORT0.6% 0.5%
CEREBROVASCULAR ACCIDENT0.6% 0.5%
ERYTHEMA0.6% 0.5%
MUSCULAR WEAKNESS0.5% 0.6%
INTENTIONAL OVERDOSE0% 0.6%
CONVULSION0% 0.6%
HALLUCINATION0% 0.6%
INJECTION SITE PAIN0.6% 0%
DRUG HYPERSENSITIVITY0.6% 0%
TACHYCARDIA0% 0.6%
HYPOGLYCAEMIA0% 0.6%
PERIPHERAL SWELLING0.6% 0%
DRY MOUTH0.6% 0%
MYOCARDIAL INFARCTION0.6% 0%
INCORRECT DOSE ADMINISTERED0.6% 0%
CHILLS0.5% 0.5%
BALANCE DISORDER0.5% 0.5%
PRODUCT USE ISSUE0.5% 0.5%
BLOOD GLUCOSE INCREASED0.5% 0.5%
AGGRESSION0% 0.5%
WITHDRAWAL SYNDROME0% 0.5%
IRRITABILITY0% 0.5%
LETHARGY0% 0.5%
RENAL FAILURE ACUTE0% 0.5%
THROMBOCYTOPENIA0% 0.5%
SEIZURE0% 0.5%
ASCITES0% 0.5%
COMA0% 0.5%
DIABETES MELLITUS0% 0.5%
SUICIDE ATTEMPT0% 0.5%
DRUG WITHDRAWAL SYNDROME0% 0.5%
GENERAL PHYSICAL HEALTH DETERIORATION0% 0.5%
EPISTAXIS0.5% 0%
AMNESIA0% 0.5%
SWELLING FACE0.5% 0%
HAEMOGLOBIN DECREASED0.5% 0%
SEPSIS0.5% 0%
PULMONARY EMBOLISM0.5% 0%
EXPIRED PRODUCT ADMINISTERED0.5% 0%
DYSPEPSIA0.5% 0%
OROPHARYNGEAL PAIN0.5% 0%
ATRIAL FIBRILLATION0.5% 0%
BRONCHITIS0.5% 0%
FLUSHING0.5% 0%
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION0.5% 0%
GASTROINTESTINAL HAEMORRHAGE0.5% 0%
VISUAL IMPAIRMENT0% 0.5%

New treatments are found every day. View current Loratadine research studies and Propranolol clinical trials

1